Johnson & Johnson: Synthes deal closes Thursday

Published



TRENTON, N.J. (AP) — Healthcare giant Johnson & Johnson said Tuesday that it will complete its $19.7 billion purchase of Synthes on Thursday — a deal J&J hopes will give it a dominant position in the growing orthopedic surgery market.

Closing the deal, the company’s biggest ever, was one of the top priorities for new CEO Alex Gorsky, who just moved up to the top spot in April after predecessor Bill Weldon retired.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.